Prescription drug · NDA
Epioxa Cross-Linking (Riboflavin 5-phosphate ophthalmic) NDC 25357-024
Kit · Ophthalmic · Glaukos Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25357-024-01 | 25357002401 | 1 KIT in 1 CARTON (25357-024-01) * 1 SYRINGE, GLASS in 1 POUCH (25357-026-01) / 2 mL in 1 SYRINGE, GLASS * 1 SYRINGE, GLASS in 1 POUCH (25357-027-01) / 2 mL in 1 SYRINGE, GLASSMarketed from Jan 16, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Epioxa Cross-Linking
- Generic name (nonproprietary)
- riboflavin 5-phosphate ophthalmic
- Dosage form
- Kit
- Route
- Ophthalmic
- Labeler
- Glaukos CorporationNDC labeler code 25357
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 219910
- Marketing start
- Listing expires
- Identifiers
- Product ID 25357-024_d8f31876-b83b-4535-b2c2-d66210c14b15SPL ID d8f31876-b83b-4535-b2c2-d66210c14b15SPL set ID 13cefc46-337c-41a3-b113-106bfe553bbbRxCUI 2727363, 2727368, 2727371, 2727373, 2727374, 2727375
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N425357002401followed by a unit qualifier and the quantityPackage 25357-0024-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EPIOXA HD and EPIOXA are indicated in epithelium-on corneal collagen cross-linking for the treatment of keratoconus in adults and pediatric patients aged 13 years and older, in conjunction with the O 2 n System and the Boost Goggles. EPIOXA HD and EPIOXA are photoenhancers indicated for use in epithelium-on corneal collagen cross-linking for the treatment of keratoconus in adults and pediatric patients aged 13 years and older, in conjunction with the O 2 n System and the Boost Goggles ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 25357-024
- What is NDC 25357-024?
- 25357-024 is the product NDC for Epioxa Cross-Linking (riboflavin 5-phosphate ophthalmic) kit, listed with the FDA by Glaukos Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Epioxa Cross-Linking (Riboflavin 5-phosphate ophthalmic).
- Who is the labeler?
- Glaukos Corporation, NDC labeler code 25357. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Epioxa Cross-Linking?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.